ConductScience.org, home
ADA2: adenosine deaminase 2
API referenceFor AI assistants

Gene · 51816

Papers4,003

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 4,003

Download this page as JSON
TitleJournalYearPMIDFound bySource
Combination pharmacotherapy for MASH: Potential synergistic approaches.Biochem Pharmacol202642767573PubTator, text miningPubMed
Schwannoma Likely Arising from the Pancreatic Head Nerve Plexus That Mimicked a Mucinous Cystic Neoplasm and Was Treated by Pancreaticoduodenectomy: A Case Report.Surg Case Rep202642719015PubTator, text miningPubMed
Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.Hepatol Res202642663409PubTator, text miningPubMed
Erdheim-Chester Disease with Breast and Axillary Involvement Diagnosed by Ultrasound-Guided Biopsy: A Case Report and Literature Review.J Clin Med202642652736PubTator, text miningPubMed
Single-cell multi-omics reveals NUF2 as a potential biomarker associated with the high-lactylation malignant state in osteosarcoma.Int J Biol Markers202642605718PubTator, text miningPubMed
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.Eur J Endocrinol202642592842PubTator, text miningPubMed
Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study.Transl Lung Cancer Res202642582700PubTator, text miningPubMed
Evaluation of lymph node micrometastasis in oral squamous cell carcinoma - A retrospective histopathological study.J Oral Maxillofac Pathol202642569725PubTator, text miningPubMed
Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy.J Pathol Clin Res202642543793PubTator, text miningPubMed
DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.Biomolecules202642509849PubTator, text miningPubMed
Cutaneous Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm: A Diagnostic Dilemma.Am J Dermatopathol202642498493PubTator, text miningPubMed
Mixture design optimization of salvianolic acid B, tanshinone IIA, butein, and formononetin from Salvia miltiorrhiza and Dalbergia odorifera for myocardial infarction.Front Pharmacol202642428511PubTator, text miningPubMed
Anifrolumab, a potential treatment for ADA2 deficiency.RMD Open202642409574PubTator, text miningPubMed
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.Lung Cancer202642385495PubTator, text miningPubMed
Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studies.Med Oncol202642371352PubTator, text miningPubMed
Study of Class I HDAC-1, -2, and -3 Inhibitors Designed by Bioisosteric Replacement of Zinc Binding Groups and Caps of Traditional Pan Inhibitors: An In Silico Approach.Curr HIV Res202642370516PubTator, text miningPubMed
Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma - two cases with imaging-pathology correlation.Front Oncol202642370128PubTator, text miningPubMed
DZNep: A Methyltransferase Modulator for Disease Mitigation.Environ Mol Mutagen202642345323PubTator, text miningPubMed
The Pan-Inhibitor of Aurora Kinases Danusertib Induces Apoptosis and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition in Human Breast Cancer Cells [Retraction].Drug Des Devel Ther202642344775PubTator, text miningPubMed
Subcutaneous extraskeletal osteosarcoma of the gluteal region: a case report from a resource-limited setting.BMC Musculoskelet Disord202642321738PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51816/papers

API referenceFor AI assistants